Axis Length and Its Relationship With Refractive Error in Chinese University Students

Sponsor
Wang Hongxia (Other)
Overall Status
Completed
CT.gov ID
NCT04666870
Collaborator
Tianjin Eye Hospital (Other)
1,901
1
6.6
286.4

Study Details

Study Description

Brief Summary

To investigate the relationship between axis length (AL) and refractive error. eyes of low hyperopia to emmetropia subjects, comprising eyes with moderate to high myopia (-11.00D ≤ SE ≤ -4.00D) were analyzed in this cross-sectional study. Cycloplegic refractive error was measured with the autorefractor, AL was measured with the IOL master. Association between AL and refractive error were evaluated by linear regression analysis. The mean of AL and its correlation with SE, sex, and age were evaluated.

Condition or Disease Intervention/Treatment Phase
  • Other: myopia or not myopia

Detailed Description

To investigate the relationship between axis length (AL) and refractive error (RE). 894 eyes with low hyperopia to emmetropia (-0.50D ≤ spherical equivalent (SE) ≤ +2.00D), comprising 1007 eyes with moderate to high myopia (-11.00D ≤ SE ≤ -4.00D) were analyzed in this study. Cycloplegic RE was measured with the autorefractor, AL was measured with the IOL master. Association between AL and refractive error were evaluated by linear regression analysis. The mean of AL and its correlation with SE, sex, and age were evaluated.

Study Design

Study Type:
Observational
Actual Enrollment :
1901 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Shanghai Guanghua Integrated Traditional Chinese and Western Medicine Hospital, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
Actual Study Start Date :
Jan 21, 2019
Actual Primary Completion Date :
Jul 30, 2019
Actual Study Completion Date :
Aug 11, 2019

Arms and Interventions

Arm Intervention/Treatment
axis length

1007 healthy students with moderate to high myopia (SE ≤ -4.00D) and 894 without myopia (-0.50D ≤ spherical power ≤ +2.00D) were enrolled.

Other: myopia or not myopia
visual acuity, IOL master biometry, the anterior segment with slit lamp, dilated fundus examination and refraction.

gender

male were 54.29% (N=1032), and female were 45.71% (N=869)

Other: myopia or not myopia
visual acuity, IOL master biometry, the anterior segment with slit lamp, dilated fundus examination and refraction.

Outcome Measures

Primary Outcome Measures

  1. Axis length [from baseline at 6 months]

    Axis length change from baseline at 6 months

  2. Refractive Error [from baseline at 6 months]

    Refractive Error change from baseline at 6 months

Eligibility Criteria

Criteria

Ages Eligible for Study:
22 Years to 26 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

with moderate to high myopia (SE ≤ -4.00D) without myopia (-0.50D ≤ spherical power ≤ +2.00D) no concurrent eye disease best corrected visual acuity is 1.0

Exclusion Criteria:

significant systemic illnesses congenital myopia, media opacity uveitis glaucoma intraocular surgery refractive surgery neurologic diseases retinal disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shanghai Guanghua Integrated Traditional Chinese and Western Medicine Hospital Shanghai Shanghai China 200052

Sponsors and Collaborators

  • Wang Hongxia
  • Tianjin Eye Hospital

Investigators

  • Study Director: Hongxia Wang, director, Shanghai Guanghua integrated traditional Chinese and Western Medicine Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wang Hongxia, Shanghai Guanghua Integrated Traditional Chinese and Western Medicine Hospital, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
ClinicalTrials.gov Identifier:
NCT04666870
Other Study ID Numbers:
  • 2020-K-106
First Posted:
Dec 14, 2020
Last Update Posted:
Dec 14, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wang Hongxia, Shanghai Guanghua Integrated Traditional Chinese and Western Medicine Hospital, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 14, 2020